Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
Published on: March 15, 2024
One Size Does Not Fit All: The Need for Sex-Specific Precision Medicine in Diabetes Technology
Stefanie Hossmann1, Susanne Tan2,3, Julia K Mader4
1Diabetes Center Berne, Bern, Switzerland.
Understanding sex-specific factors in diabetes is crucial for precision medicine. Research must address female-specific pathophysiology across life stages, lifestyle, and insulin pharmacology to improve glycemic control.
Area of Science:
- Endocrinology and Metabolism
- Reproductive Health
- Precision Medicine
Background:
- Precision medicine requires integrating sex-specific factors in diabetes research and treatment.
- Significant gaps exist in understanding and applying sex-related differences in diabetes care.
- Female-specific pathophysiology, influenced by life cycle, lifestyle, and insulin pharmacology, impacts glycemic control.
Purpose of the Study:
- To highlight critical gaps in understanding and applying sex-specific factors in diabetes.
- To emphasize the need for greater research and clinical focus on female-specific diabetes pathophysiology.
- To advocate for systematic and effective care by addressing sex-based differences.
Main Methods:
- Literature review and synthesis of current research on sex differences in diabetes.
- Analysis of female-specific pathophysiology across life cycle phases, lifestyle factors, and insulin pharmacology.
- Identification of evidence gaps in research and clinical practice.
Main Results:
- Female-specific diabetes pathophysiology is influenced by puberty, pregnancy, menopause, nutrition, physical activity, and insulin pharmacology.
- These factors significantly affect insulin sensitivity and glycemic control in women.
- Current research and clinical practice often underrepresent or ignore these sex-based differences.
Conclusions:
- Addressing sex-specific factors is essential for advancing precision medicine in diabetes.
- Greater research and clinical attention are needed to understand and manage sex-based differences in diabetes.
- Identifying and filling evidence gaps will lead to more systematic and effective diabetes care for women.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
